The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-((6,7-Dimethoxy-4-((1-methylpiperidin-4-yl)amino)quinazolin-2-yl)(methyl)amino)ethan-1-ol ID: ALA4069640
PubChem CID: 137639969
Max Phase: Preclinical
Molecular Formula: C19H29N5O3
Molecular Weight: 375.47
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc2nc(N(C)CCO)nc(NC3CCN(C)CC3)c2cc1OC
Standard InChI: InChI=1S/C19H29N5O3/c1-23-7-5-13(6-8-23)20-18-14-11-16(26-3)17(27-4)12-15(14)21-19(22-18)24(2)9-10-25/h11-13,25H,5-10H2,1-4H3,(H,20,21,22)
Standard InChI Key: DJKVIUVJRXEKNV-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
5.9748 -18.4982 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9737 -19.3177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6817 -19.7267 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6799 -18.0893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3885 -18.4946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3893 -19.3136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0978 -19.7207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8061 -19.3099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8014 -18.4877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0923 -18.0844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6775 -17.2722 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5066 -18.0748 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.2168 -18.4791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5154 -19.7157 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.2215 -19.3044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9686 -16.8657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9687 -16.0450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2639 -15.6386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5550 -16.0458 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5554 -16.8640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2648 -17.2749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8476 -15.6367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2656 -19.7258 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5582 -19.3166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2650 -20.5430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8502 -19.7247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1428 -19.3155 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
4 11 1 0
9 12 1 0
12 13 1 0
8 14 1 0
14 15 1 0
11 16 1 0
16 17 1 0
16 21 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
19 22 1 0
2 23 1 0
23 24 1 0
23 25 1 0
24 26 1 0
26 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 375.47Molecular Weight (Monoisotopic): 375.2270AlogP: 1.58#Rotatable Bonds: 7Polar Surface Area: 82.98Molecular Species: BASEHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.77CX LogP: 1.30CX LogD: -0.23Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.75Np Likeness Score: -0.94
References 1. Xiong Y, Li F, Babault N, Wu H, Dong A, Zeng H, Chen X, Arrowsmith CH, Brown PJ, Liu J, Vedadi M, Jin J.. (2017) Structure-activity relationship studies of G9a-like protein (GLP) inhibitors., 25 (16): [PMID:28662962 ] [10.1016/j.bmc.2017.06.021 ]